Macrophage infiltration in human non-small-cell lung cancer: The role of CC chemokines

Cancer Immunology Immunotherapy

Volumn 49, Issue 2, 2000, Pages 63-70

  Arenberg, Douglas A ^a   Keane, Michael P ^a   DiGiovine, Bruno ^b   Kunkel, Steven L ^a   Strom, Scott R B ^a   Burdick, Marie D ^a   Iannettoni, Mark D ^a   Strieter, Robert M ^c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemokine; Macrophage; Tumor

Indexed keywords

BETA CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; RANTES;

ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG NON SMALL CELL CANCER; MACROPHAGE ACTIVATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; HUMANS; LUNG NEOPLASMS; MACROPHAGES; MONOCYTES; PROSPECTIVE STUDIES;

EID: 0033932443     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050603     Document Type: Article

References (45)

1. 1. Acero R, Polentarutti N, Bottazzi B, Alberti S, Ricci MR, Bizzi A, Mantovani A (1984) Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumors. Int J Cancer 33: 95
2. 2. Alexander P (1974) Proceedings: escape from immune destruction by the host through shedding of surface antigens: is this a characteristic shared by malignant and embryonic cells? Cancer Res 34: 2077
3. 3. Audran R, Dazord L, Toujas L (1994) Interactions between human macrophages and tumor cells in three-dimensional cultures. Cancer Immunol Immunother 39: 299
4. 4. Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394: 894
5. 5. Bottazzi B, Colotta F, Sica A, Nobili N, Mantovani A (1990) A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int J Cancer 45: 795
6. 6. Bottazzi B, Walter S, Govoni D, Colotta F, Mantovani A (1992) Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J Immunol 148: 1280
7. 7. Burdick MD, Kunkel SL, Lincoln PM, Wilke CA, Strieter RM (1993) Specific ELISAs for the detection of human macrophage inflammatory protein-1 alpha and beta. Immunol Invest 22: 441
8. 8. Chensue SW, Warmington KS, Ruth JH, Sanghi PS, Lincoln P, Kunkel SL (1996) Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. J Immunol 157: 4602
9. 9. Cohen EP, Kim TS (1994) Neoplastic cells that express low levels of MHC class I determinants escape host immunity. Semin Cancer Biol 5: 419
10. 10. Davey GC, Currie GA, Alexander P (1976) Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: correlation with metastic capacity. Br J Cancer 33: 9
11. 11. Desbaillets I, Tada M, Tribolet N de, Diserens AC, Hamou MF, Van Meir EG (1994) Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int J Cancer 58: 240
12. 12. Edwards MJ, Anderson JA, Angel JR, Harty JI (1996) Spontaneous regression of primary and metastatic renal cell carcinoma. J Urol 155: 1385
13. 13. Endress H, Freudenberg N, Fitzke E, Grahmann PR, Hasse J, Dieter P (1997) Infiltration of lung carcinomas with macrophages of the 27E10-positive phenotype. Lung Cancer 18: 35
14. 14. Evanoff HL, Burdick MD, Moore SA, Kunkel SL, Strieter RM (1992) A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol Invest 21: 39
15. 15. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF (1999) MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103: 773
16. 16. Gu L, Rutledge B, Fiorillo J, Ernst C, Grewal I, Flavell R, Gladue R, Rollins B (1997) In vivo properties of monocyte chemoattractant protein-1. J Leukoc Biol 62: 577
17. 17. Hirose K, Hakozaki M, Nyunoya Y, Kobayashi Y, Matsushita K, Takenouchi T, Mikata A, Mukaida N, Matsushima K (1995) Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br J Cancer 72: 708
18. 18. Huang S, Singh RK, Xie K, Gutman M, Berry KK, Bucana CD, Fidler IJ, Bar-Eli M (1994) Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol Immunother 39: 231
19. 19. Karpus WJ, Lukacs NW (1996) The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1. Ann N Y Acad Sci 778: 133
20. 20. Kasama T, Strieter RM, Standiford TJ, Burdick MD, Kunkel SL (1993) Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha. J Exp Med 178: 63
21. 21. Khar A, Muralikrishna K, Varalakshmi C (1997) High intratumoural level of cytokines mediates efficient regression of a rat histiocytoma. Clin Exp Immunol 110: 127
22. 22. Leek RD, Landers RJ, Harris AL, Lewis CE (1999) Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79: 991
23. 23. Lukacs NW, Chensue SW, Karpus WJ, Lincoln P, Keefer C, Strieter RM, Kunkel SL (1997) C-C chemokines differentially alter interleukin-4 production from lymphocytes. Am J Pathol 150: 1861
24. 24. Mantovani A (1981) In vitro effects on tumor cells of macrophages isolated from an early-passage chemically-induced murine sarcoma and from its spontaneous metastases. Int J Cancer 27: 221
25. 25. Mantovani A (1994) Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 71: 5
26. 26. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G, Balkwill F (1999) Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 5: 828
27. 27. Nakashima E, Oya A, Kubota Y, Kanada N, Matsushita R, Takeda K, Ichimura F, Kuno K, Mukaida N, Hirose K, Nakanishi I, Ujiie T, Matsushima K (1996) A candidate for cancer gene therapy: MIP-1 alpha gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice. Pharm Res 13: 1896
28. 28. Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, Bernasconi S, Allavena P, Sozzani S, Mantovani A, Balkwill FR (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95: 2391
29. 29. Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H, Ito Y, Inamura T, Ikezaki K, Fukui M, Iwaki T, Kuwano M (1999) Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas (in Process Citation). Clin Cancer Res 5: 1107
30. 30. Nordquist RE, Anglin JH, Lerner MP (1977) Antibody-induced antigen redistribution and shedding from human breast cancer cells. Science 197: 366
31. 31. Nordquist RE, Anglin JH, Lerner MP (1978) Antigen shedding by human breast-cancer cells in vitro and in vivo. Br J Cancer 37: 776
32. 32. Opdenakker G, Froyen G, Fiten P, Proost P, Van Damme J (1993) Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. Biochem Biophys Res Commun 191: 535
33. 33. Orre M, Rogers PA (1999) Macrophages and microvessel density in tumors of the ovary. Gynecol Oncol 73: 47
34. 34. Papac RJ (1996) Spontaneous regression of cancer. Cancer Treat Rev 22: 395
35. 35. Polverini PJ, Leibovich SJ (1984) Induction of neovascularization in vivo and endothelial cell proliferation in vitro by tumor-associated macrophages. Lab Invest 51: 635
36. 36. Rollins BJ, Sunday ME (1991) Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol Cell Biol 11: 3125
37. 37. Shoji M, Hancock WW, Abe K, Micko C, Casper KA, Baine RM, Wilcox JN, Danave I, Dillehay DL, Matthews E, Contrino J, Morrissey JH, Gordon S, Edgington TS, Kudryk B, Kreutzer DL, Rickles FR (1998) Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol 152: 399
38. 38. Smith DR, Kunkel SL, Standiford TJ, Chensue SW, Rolfe MW, Orringer MB, Whyte RI, Burdick MD, Danforth JM, Gilbert AR, Strieter RM (1993) The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma. Am J Pathol 143: 794
39. 39. Smith DR, Kunkel SL, Burdick MD, Wilke CM, Orringer MB, Whyte RI, Strieter RM (1994) Production of interleukin-10 by human bronchogenic carcinoma. Am J Pathol 145: 18
40. 40. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP, Toews GB, Westwick J, Strieter RM (1990). Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J Clin Invest 86: 1945
41. 41. Standiford TJ, Rolfe MW, Kunkel SL, Lynch JPD, Burdick MD, Gilbert AR, Orringer MB, Whyte RI, Strieter RM (1993) Macrophage inflammatory protein-1 alpha expression in interstitial lung disease. J Immunol 151: 2852
42. 42. VanOtteren GM, Standiford TJ, Kunkel SL, Danforth JM, Burdick MD, Abruzzo LV, Strieter RM (1994) Expression and regulation of macrophage inflammatory protein-1 alpha by murine alveolar and peritoneal macrophages. Am J Respir Cell Mol Biol 10: 8
43. 43. Vegh Z, Wang P, Vanky F, Klein E (1993) Selectively down-regulated expression of major histocompatibility complex class I alleles in human solid tumors. Cancer Res 53: 2416
44. 44. Vitolo D, Zerbe T, Kanbour A, Dahl C, Herberman RB, Whiteside TL (1992) Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int Cancer 51: 573
45. 45. Webb LM, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A (1993) Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA 90: 7158